Who will respond to intensive PTSD treatment? A machine learning approach to predicting response prior to starting treatment.

Machine learning Massed treatment PTSD Precision medicine Trajectory modeling Treatment response Veterans

Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
07 2022
Historique:
received: 11 10 2021
revised: 09 03 2022
accepted: 31 03 2022
pubmed: 26 4 2022
medline: 18 6 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

Despite the established effectiveness of evidence-based PTSD treatments, not everyone responds the same. Specifically, some individuals respond early while others respond minimally throughout treatment. Our ability to predict these trajectories at baseline has been limited. Predicting which individuals will respond to a certain type of treatment can significantly reduce short- and long-term costs and increase the ability to preemptively match individuals with treatments to which they are most likely to respond. In the present study, we examined whether veterans' responses to a 3-week Cognitive Processing Therapy-based intensive PTSD treatment program could be accurately predicted prior to the first session. Using a sample of 432 veterans, and a wide range of demographic and clinical data collected during intake, we assessed six machine learning and statistical methods and their ability to predict fast and minimal responders prior to treatment initiation. For fast response classification, gradient boosted models (GBM) had the highest AUC-PR (0.466). For minimal response classification, elastic net (EN) had the highest mean CV AUC-PR (0.628). Using the best performing classifiers, we were able to predict both fast and minimal responders prior to starting treatment with relatively high AUC-ROC of 0.765 (GBM) and 0.826 (EN), respectively. These results may inform treatment modifications, although the accuracy may not be sufficient for clinicians to base inclusion/exclusion decisions entirely on the classifiers. Future research should evaluate whether these classifiers can be expanded to predict to which treatment type(s) an individual is most likely to respond based on various clinical, circumstantial, and biological features.

Identifiants

pubmed: 35468429
pii: S0022-3956(22)00194-7
doi: 10.1016/j.jpsychires.2022.03.066
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-85

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Philip Held (P)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA. Electronic address: Philip_Held@rush.edu.

Ryan A Schubert (RA)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Sarah Pridgen (S)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Merdijana Kovacevic (M)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Mauricio Montes (M)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Nicole M Christ (NM)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Uddyalok Banerjee (U)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Dale L Smith (DL)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Department of Behavioral Sciences, Olivet Nazarene University, Bourbonnais, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH